High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma

Annals of Oncology

Volumn 9, Issue 9, 1998, Pages 1023-1026

  Pavletic, Z S ^a,b   Bierman, P J ^a   Vose, J M ^a   Bishop, M R ^a   Wu, C D ^a   Pierson, J L ^b   Kollath, J P ^b   Weisenburger, D D ^a   Kessinger, A ^a   Armitage, J O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Autologous hematopoietic stem cell transplantation; Chronic lymphocytic leukemia; Relapse rate; Small lymphocytic lymphoma

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE DERIVATIVE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IFOSFAMIDE; MESNA; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; B CELL LEUKEMIA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHEMOSENSITIVITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LEUKEMIA, B-CELL, CHRONIC; LYMPHOMA, SMALL LYMPHOCYTIC; MALE; MIDDLE AGED; NEOPLASM REGRESSION, SPONTANEOUS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 7844232969     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008474526373     Document Type: Article

References (25)

1. Rozman C, Montserral E. Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052-7.
2. Keating MJ, O'Brien S, Kantarjian H et al. Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood 1993; 81: 2878-84.
3. Rabinowe SN, Soiffer RJ, Gribben JG et al. Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1366-76.
4. Khouri IF, Keating MJ, Vriesendorp HM et al. Autologuos and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: Preliminary results. J Clin Oncol 1994; 12: 748-58.
5. Michallet M, Archimbaud E, Bandini G et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. Ann Intern Med 1996; 124: 311-5.
6. Esteve J, Villamor N, Colomer D et al. Hematopoietic stem-cell transplantation in chronic lymphocytic leukemia: A report of 12 patients from a single institution. Ann Oncol 1998; 9: 167-72.
7. Khouri IF, Keating MJ. High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit? Ann Oncol 1998; 9: 131-2.
8. Khouri IF, Przepiorka D, Van Besien K et al. Allogeneic blood or marrow transplantation for chronic lymphocytic leukemia: Timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Br J Hematol 1997; 97: 466-73.
9. Dreger P, Schmitz N. The role of stem-cell transplantation in the treatment of chronic lymphocytic leukemia. Leukemia 1997; 11 (Suppl 2): S42-5.
10. Montserrat E, Gomis F, Vallespi T et al. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood 1991; 78: 1545-51.
11. Michallet M, Bandini G. High-dose therapy and bone marrow transplantation in chronic lymphocytic leukemia. In Armitage JO, Antman KH (eds): High-dose Cancer Therapy. Baltimore, MD: Williams & Wilkins 1995; 715-27.
12. Harris N L, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 1994; 84: 1361-92.
13. Bishop MR, Anderson JR, Jackson JD et al. High-dose therapy and peripheral blood progenitor cell transplantation: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 1993; 83: 610-6.
14. Keating MJ, Lerner S, Kantarjian H et al. The serum β2-microglobulin level is more powerful than stage in predicting response and survival in chronic lymphocytic leukemia. Blood 1995; 86 (Suppl 1): 606a.
15. Horowitz MM. New IBMTR/ABMTR slides summarize current use and outcome of allogeneic and autologous transplants. IBMTR Newsletter 1995; 2: 2-8.
16. Provan D, Bartlett-Pandite L, Zwicky C et al. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 1996; 88: 228-35.
17. Bartlett-Pandite L, Gribben JG, Soiffer R et al. Potential for cure of B-cell CLL and SLL: Prolonged disease free survival and molecular remissions following autologous and allogeneic bone marrow transplantation. Blood 1996; 88: 718a.
18. Khouri I. Current status of bone marrow transplantation in chronic lymphocytic leukemia. In Jain V (ed): CLL The Cutting Edge. Dallas, TX: Innovative Medical Communications 1997; 5-7.
19. Gahn B, Schafer C, Neef J et al. Rapid communication - detection of Trisomy 12 and Rb-deletion in CD34+ cells of patients with B-cell chronic lymphocytic leukemia. Blood 1997; 89: 4275-81.
20. Consoli U, El-Tounsi I, Sandoval A et al. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia. Blood 1998; 91: 1742-8.
21. Osterborg A, Dyer MJ, Bunjes D et al. Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. J Clin Oncol 1997; 15: 1567-74.
22. Mehta J, Powles R, Sinhgal S et al. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: Possible role of graft-versus-leukemia. BMT 1996; 17: 71-5.
23. Rondon G, Giralt S, Huh Y et al. Case report - graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia. BMT 1996; 18: 669-72.
24. Pavletic Z, Bierman P, Bishop M et al. Autologous or allogeneic stem-cell transplantation for B-cell chronic lymphocytic leukemia: A single institution report. Proc Am Soc Clin Oncol 1997; 16: 109.
25. Khouri I, Keating MJ, Przepiorka D et al. Engraftment and induction of GVL with fludarabine-based non-ablative preparative regimen in patients with chronic lymphocytic leukemia. Blood 1996; 88: 301a.